WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search

QL ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
QL01 ANTINEOPLASTIC AGENTS
QL01X OTHER ANTINEOPLASTIC AGENTS
QL01XX Other antineoplastic agents
QL01XX01 amsacrine
QL01XX02 asparaginase
QL01XX03 altretamine
QL01XX05 hydroxycarbamide
QL01XX07 lonidamine
QL01XX08 pentostatin
QL01XX09 miltefosine
QL01XX10 masoprocol
QL01XX11 estramustine
QL01XX14 tretinoin
QL01XX16 mitoguazone
QL01XX17 topotecan
QL01XX18 tiazofurin
QL01XX19 irinotecan
QL01XX22 alitretinoin
QL01XX23 mitotane
QL01XX24 pegaspargase
QL01XX25 bexarotene
QL01XX27 arsenic trioxide
QL01XX29 denileukin diftitox
QL01XX32 bortezomib
QL01XX33 celecoxib
QL01XX35 anagrelide
QL01XX36 oblimersen
QL01XX37 sitimagene ceradenovec
QL01XX38 vorinostat
QL01XX39 romidepsin
QL01XX40 omacetaxine mepesuccinate
QL01XX41 eribulin
QL01XX42 panobinostat
QL01XX43 vismodegib
QL01XX44 aflibercept
QL01XX45 carfilzomib
QL01XX46 olaparib
QL01XX47 idelalisib
QL01XX48 sonidegib
QL01XX49 belinostat
QL01XX50 ixazomib
QL01XX51 talimogene laherparepvec
QL01XX52 venetoclax
QL01XX53 vosaroxin
QL01XX54 niraparib
QL01XX55 rucaparib
QL01XX56 etirinotecan pegol
QL01XX57 plitidepsin
QL01XX58 epacadostat
QL01XX59 enasidenib
QL01XX60 talazoparib
QL01XX61 copanlisib
QL01XX91 tigilanol tiglate

Last updated: 2019-01-21